T0	Participants 58 95	coronary artery bypass graft patency.
T1	Participants 298 353	610 patients undergoing coronary artery bypass grafting
T2	Participants 462 537	All patients received antithrombotic treatment, either aspirin or warfarin.
T3	Participants 1323 1374	patients undergoing coronary artery bypass grafting